Elon Musk’s Neuralink Enters New Era with Brain Chip Implantation in Humans

After missing prior deadlines set by the billionaire CEO, Elon Musk anticipates that human clinical trials for a coin-sized, wireless brain chip built by his business Neuralink will begin in six months. Neuralink is creating brain chip interfaces that, according to Musk, will also focus on regaining eyesight and allowing crippled people to move and communicate once again.

Neuralink, a company with offices in Austin, Texas, and the San Francisco Bay Area, has recently begun testing its products on animals in order to obtain the US Food and Drug Administration’s (FDA) consent to start clinical trials.

Musk said at a much anticipated public update on the gadget on Wednesday that “we want to be extremely careful and certain that it will work well before putting a device into a human.

“The progress at first will seem perhaps agonizingly slow, especially as it relates to humans, but we are doing all of the things to bring it to scale in parallel,” he continued. Therefore, advancement ought to be exponential in theory.

According to Musk, the Neuralink device’s first two human uses would be to restore eyesight and allow those who are unable to move their muscles to do so. “We believe we can still restore vision,” he stated, “even if someone has never had a vision, ever, like they were born blind.”

Read More: Nick Carter Sued for Sexual Assault, Battery by Dream Singer Melissa Schuman

Grandiose Goals Are Falling Behind Schedule

Ariana Madix Feels 'Amazing' at Coachella After Tom Sandoval Break Up

Musk canceled the event just a few days before it was scheduled for October 31 without providing a reason. More than a year ago, Neuralink gave its final public demonstration, which included a monkey playing Pong on a computer.

Musk, who also owns the electric vehicle maker Tesla, the rocket company SpaceX, and the social networking site Twitter, is renowned for his aspirational plans to save mankind and colonize Mars.

The same lofty goals are held for Neuralink, which he founded in 2016.

He intends to create a chip that would enable the brain to operate intricate electrical equipment, eventually restoring motor function to paralyzed persons and treating disorders of the brain including Parkinson’s, dementia, and Alzheimer’s. He also discusses combining artificial intelligence with the brain.

However, Neuralink is going behind schedule. In a 2019 presentation, Musk stated that his goal was to win regulatory permission by the end of 2020. Then, in late 2021, he declared at a conference that he wanted to begin human trials this year.

Read More: After Experiencing a “Medical Complication,” Jamie Foxx Is Now “On His Way to Recovery”

Ariana Madix Feels 'Amazing' at Coachella After Tom Sandoval Break Up

Current and former workers claim that Neuralink has routinely missed internal deadlines for obtaining FDA clearance to begin human studies. A brain interface created by rival firm Synchron to enable paralyzed persons to remotely manage digital gadgets through thinking has already advanced with human testing.

The neural implant that is being tested instead inserts itself into the brain through a tiny incision in the neck, up through the jugular vein.

Synchron achieved a significant milestone in July when it successfully completed research on four individuals in Australia and implanted its device in a patient for the first time in the United States.

According to Reuters, Musk contacted Synchron early this year about a prospective investment after complaining to Neuralink staff members about their sluggish development.